JUN 01, 2015 2:33 PM PDT

3-D Brain Models Could Be Diagnostic Tool for Doctors

WRITTEN BY: Will Hector
There are a few essential ways to understand the neural workings of the human brain. One is to painstakingly map the circuitry using computers. See a fascinating article in the January 8, 2015, New York Times magazine on Sebastian Seung's work for more on this.

There's the Human Connectome Project's work on building a connectome, or map of the neural connections with the goal of establishing a baseline for a healthy brain's anatomical and functional connectivity and facilitate research on disorders such as Alzheimer's, dyslexia, autism, and schizophrenia.
Cortical neurons and supporting cells form layers and organize themselves according to the architecture of the developing human brain.
Then, there's the lab down the hall where the really wild stuff occurs. In this case, imagine Sergiu Pasca's name on the door. Pasca and his Stanford colleagues introduced what they call human cortical spheroids in the May 25 edition of the journal Nature Methods.

Pasca's human cortical spheroids are cultured 3-D structures that grow and function much like a miniature version of the cortex of the subject from whom the original tissue was drawn. The mini brain models, or "organoids," feature neural networks through which cells actively communicate. Theoretically, the models would show doctors, psychiatrists, and psychologists any abnormalities in connectivity that might assist with diagnosis and treatment planning.

Thomas R. Insel, M.D., Director of the NIH's National Institute of Mental Health (most of the funding for the study came from the National Institutes of Health), commented on the findings: "There's been amazing progress in this field over the past few years. The cortex spheroids grow to a state in which they express functional connectivity, allowing for modeling and understanding of mental illnesses. They do not even begin to approach the complexity of a whole human brain. But that is not exactly what we need to study disorders of brain circuitry. As we seek advances that promise enormous potential benefits to patients, we are ever mindful of the ethical issues they present."

Science has long theorized that an organism passes through embryonic development in stages that loosely mirror the evolution of that organism. This process, called recapitulation, is currently popular in somatic psychology work. It has been accomplished using stem cells in 3-D cultures. These experiments have revealed patterns similar to corticogenesis, the process through which the cerebral cortex is created.

Prior to Pasca's study, researchers had studied neurons derived from patients' skin cells using something called induced pluripotent stem cells, or iPSCs. They produced rough organoids that mimicked the brain's own architecture, but lacked the complex circuitry required to study the human brain's workings.

Pasca's team utilized an improved method to produce iPSCs that more closely resembled the neural connectivity and circuitry of the human brain, including support of glial cells and forming of layers-also a key component of corticogenesis. The model can also succumb to the process of mico thin slicing as a way to map the brain.

"While the technology is still maturing, there is great potential for using these assays to more accurately develop, test safety and effectiveness of new treatments before they are used in individuals with a mental illness," said David Panchision, Ph.D., NIMH program director for stem cell research.

Follow Will Hector on Twitter: @WriterWithHeart

(Source: Nature Methods; Science Daily)
About the Author
  • Will Hector practices psychotherapy at Heart in Balance Counseling Center in Oakland, California. He has substantial training in Attachment Theory, Hakomi Body-Centered Psychotherapy, Psycho-Physical Therapy, and Formative Psychology. To learn more about his practice, click here: http://www.heartinbalancetherapy.com/will-hector.html
You May Also Like
JUL 27, 2021
Technology
First Prescription Digital Therapeutic Expands Access to Mental Health Care
JUL 27, 2021
First Prescription Digital Therapeutic Expands Access to Mental Health Care
Treatment for disorders like depression and anxiety usually requires regular visits to a psychiatrist or, at the very le ...
AUG 01, 2021
Drug Discovery & Development
New Compound Halts Neurodegeneration in Alzheimer's
AUG 01, 2021
New Compound Halts Neurodegeneration in Alzheimer's
Chemists have synthesized new compounds that can halt neurodegeneration linked to Alzheimer’s and other neurologic ...
AUG 15, 2021
Neuroscience
Cholesterol in the Brain Linked to Alzheimer's Plaques
AUG 15, 2021
Cholesterol in the Brain Linked to Alzheimer's Plaques
Cholesterol levels in the brain tightly regulate the production of amyloid-beta plaques in the brain, a key feature of A ...
AUG 17, 2021
Drug Discovery & Development
Severe daytime sleepiness? A new drug can help: FDA approves Xywav to treat idiopathic hypersomnia.
AUG 17, 2021
Severe daytime sleepiness? A new drug can help: FDA approves Xywav to treat idiopathic hypersomnia.
     Being tired throughout the day is a common feeling for most individuals. In fact, 1 out of every 5 A ...
AUG 18, 2021
Neuroscience
Histamine Regulates Serotonin Levels in Depression
AUG 18, 2021
Histamine Regulates Serotonin Levels in Depression
Heightened histamine levels from inflammation inhibit the effects of the mood-regulating neurotransmitter serotonin in t ...
SEP 01, 2021
Health & Medicine
Does Regular Cannabis Affect Brain Function? Sometimes in a Good Way
SEP 01, 2021
Does Regular Cannabis Affect Brain Function? Sometimes in a Good Way
With cannabis now legal in many parts of the world, an increasing number of people now count as regular users of the dru ...
Loading Comments...